![](/img/cover-not-exists.png)
CostâUtility Analysis of Pembrolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer With Different PD-L1 Expression Levels
Weng, Xiuhua, Luo, Shaohong, Lin, Shen, Zhong, Lixian, Li, Meiyue, Xin, Rao, Huang, Pinfang, Xu, XiongweiVolume:
28
Language:
english
Journal:
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
DOI:
10.3727/096504019X15707883083132
Date:
March, 2020
File:
PDF, 663 KB
english, 2020